ECS Botanics (ASX:ECS) witnessed a surge in its shares by 40.9% to A$0.031, marking the biggest intraday percentage gain since December 8, 2020.

The medicinal cannabis company has secured a binding off-take agreement to supply medicinal cannabis dried flower for the next five years to Perth-based medicinal cannabis company, MediCann Health.

Under this deal, ECS Botanics (ASX:ECS) will provide A$24 million of pharmaceutical-grade cannabis dried flower to MediCann starting January 2024.

The shares reached their pinnacle since February 10, 2022.

Around 15.6 million shares traded hands in contrast with to the 30-day average of 1.4 million shares.

The stock of ECS (ASX:ECS) went up by 10% YTD at the clos of the last trading session.

ECS Botanics is a company specialized in the production and supply of medicinal-grade cannabis dried flower.